Agios Pharm
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $8,964 | $8,615 | $8,189 | $7,103 |
Gross Profit | 8,181 | 5,527 | 6,214 | 5,114 |
EBITDA | 1,002,380 | -104,224 | -90,724 | -104,874 |
EBIT | 1,001,035 | -105,817 | -92,072 | -106,277 |
Net Income | 947,915 | -96,118 | -81,549 | -95,940 |
Net Change In Cash | 8,964 | 8,615 | 8,189 | 7,103 |
Free Cash Flow | -84,637 | -72,747 | -100,008 | -72,722 |
Cash | 253,730 | 84,518 | 118,764 | 88,205 |
Basic Shares | 58,432 | 56,802 | 56,383 | 55,897 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $26,823 | $14,240 | $41 | $203,196 |
Gross Profit | 17,319 | 12,536 | -18,777 | 200,391 |
EBITDA | -384,864 | -380,483 | -337,733 | -326,126 |
EBIT | -391,487 | -399,042 | -356,510 | -344,898 |
Net Income | -352,088 | -74,555 | 1,604,715 | -335,218 |
Net Change In Cash | 26,823 | 14,240 | 41 | 203,196 |
Cost of Revenue | -63,867 | 75,690 | 46,505 | |
Free Cash Flow | -297,061 | -314,359 | -413,061 | -305,668 |
Cash | 88,205 | 139,259 | 203,126 | 127,436 |
Basic Shares | 55,651 | 54,789 | 60,447 | 68,997 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.42 |
2024-06-30 | -$1.69 |
2024-03-31 | -$1.45 |
2023-12-31 | -$1.72 |
